Oramed Pharmaceuticals Inc. (TLV:ORMP)
Israel
· Delayed Price · Currency is ILS · Price in ILA 733.70
-7.40 (-1.00%)
Jun 26, 2025, 5:24 PM IDT
Oramed Pharmaceuticals Market Cap
Oramed Pharmaceuticals has a market cap or net worth of 300.48 million as of June 27, 2025. Its market cap has decreased by -3.42% in one year.
Market Cap
300.48M
Enterprise Value
-144.45M
Revenue
7.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
733.70
Market Cap Chart
Since March 19, 2004, Oramed Pharmaceuticals's market cap has increased from 2.37M to 300.48M, an increase of 12,571.47%. That is a compound annual growth rate of 25.54%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 66.64B |
| Danel (Adir Yeoshua) | 2.70B |
| Kamada | 1.53B |
| Bait Bakfar | 1.06B |
| BrainsWay | 801.90M |
| Novolog (Pharm-Up 1966) | 722.84M |
| Ilex Medical | 711.56M |
| SofWave Medical | 709.22M |